Lee S Schwartzberg Lesli A Kiedrowski
10.1177/17588359211006962
Ther Adv Med Oncol
2021 Apr 5;13:17588359211006962.
parp inhibitor breast cancer metastasis olaparib somatic brca2 mutations
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33868464/
Case Reports
PMC8024449
33868464
Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation
2021